Literature DB >> 19488753

Increased bone resorption is implicated in the pathogenesis of bone loss in hemophiliacs: correlations with hemophilic arthropathy and HIV infection.

Olga Katsarou1, Evangelos Terpos, Pantelis Chatzismalis, Stefanos Provelengios, Theophanis Adraktas, Dimitrios Hadjidakis, Anna Kouramba, Anastasia Karafoulidou.   

Abstract

Osteoporosis has been recently recognized as a severe comorbidity factor in hemophilia. However, its pathogenesis is still obscure. We evaluated the incidence of osteoporosis in 90 hemophilia patients and investigated possible correlations with clinical and laboratory data. Out of the 90 patients, 80 (89%) had severe hemophilia, and 35 (38.9%) were human immunodeficiency virus (HIV)-positive. Hemophilic arthropahty was assessed using World Federation of Hemophilia clinical score and Petterson radiological score. Bone mineral density of the lumbar spine (LS) and femoral neck (FN) were measured using dual-energy X-ray absortiometry. Bone turnover was evaluated by the measurement of: (1) bone resorption markers [N-terminal cross-linking telopeptide of collagen type I (NTX), C-terminal cross-linking telopeptide of collagen type I (CTX), and tartrate-resistant acid phosphatase isoform-5b (TRACP-5b)], (2) bone formation markers [bone-alkaline phosphatase (bALP) and osteocalcin], and (3) osteoclast stimulators (receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and tumor necrosis factor-alpha). Osteopenia or osteoporosis was observed in 86% and 65% of the patients in FN and LS, respectively. Osteoporosis was more common among HIV-positive patients in both FN (65.3% vs 41.6%; p = 0.007) and LS (17.86% vs 5.41%, p = 0.004). The severity of osteoporosis in FN correlated with the patients' total clinical and radiological score (p = 0.001). Hemophilia patients showed increased osteoclastic activity (significant increase of TRACP-5b, NTX, and CTX), which was not accompanied by a comparable increased bone formation (reduced osteocalcin and borderline increase of bALP). In multivariate analysis, HIV infection (p = 0.05) and total clinical score (p = 0.001) were independent risk factors for osteoporosis development. We conclude that there is a high prevalence of osteoporosis among hemophiliacs, which is related to the severity of arthropathy and is enhanced by HIV infection. We report for the first time a high bone resorption that seems not to be balanced by a comparable bone formation.

Entities:  

Mesh:

Year:  2009        PMID: 19488753     DOI: 10.1007/s00277-009-0759-x

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  16 in total

Review 1.  Bleeding disorders and reduced bone density.

Authors:  Hassan Mansouritorghabeh; Zahra Rezaieyazdi
Journal:  Rheumatol Int       Date:  2010-05-27       Impact factor: 2.631

Review 2.  Pathological mechanism of joint destruction in haemophilic arthropathy.

Authors:  Haijia Zhu; Yilin Meng; Peijian Tong; Shanxing Zhang
Journal:  Mol Biol Rep       Date:  2020-12-08       Impact factor: 2.316

3.  Evaluation of bone mineral density (BMD) and indicators of bone turnover in patients with hemophilia.

Authors:  Mehmet Dagli; Ali Kutlucan; Sedat Abusoglu; Abdulkadir Basturk; Mehmet Sozen; Leyla Kutlucan; Ali Unlu; Farise Yilmaz
Journal:  Bosn J Basic Med Sci       Date:  2018-05-20       Impact factor: 3.363

4.  Bone density in haemophilia: a single institutional cross-sectional study.

Authors:  C L Kempton; A Antun; D M Antoniucci; W Carpenter; M Ribeiro; S Stein; L Slovensky; L Elon
Journal:  Haemophilia       Date:  2013-08-01       Impact factor: 4.287

5.  Inflammatory focal bone destruction in femoral heads with end-stage haemophilic arthropathy: a study on clinic samples with micro-CT and histological analyses.

Authors:  S Zhang; C Lu; J Ying; P Wang; T Xu; D Chen; H Jin; P Tong
Journal:  Haemophilia       Date:  2015-09-20       Impact factor: 4.287

6.  Reduced bone formation in males and increased bone resorption in females drive bone loss in hemophilia A mice.

Authors:  M Neale Weitzmann; Susanne Roser-Page; Tatyana Vikulina; Daiana Weiss; Li Hao; W Hunter Baldwin; Kanglun Yu; Natalia Del Mazo Arbona; Meghan E McGee-Lawrence; Shannon L Meeks; Christine L Kempton
Journal:  Blood Adv       Date:  2019-02-12

7.  An update on the role of RANKL-RANK/osteoprotegerin and WNT-ß-catenin signaling pathways in pediatric diseases.

Authors:  Giacomina Brunetti; Gabriele D'Amato; Mariangela Chiarito; Apollonia Tullo; Graziana Colaianni; Silvia Colucci; Maria Grano; Maria Felicia Faienza
Journal:  World J Pediatr       Date:  2018-10-20       Impact factor: 2.764

8.  Relationship between Biochemical Bone Markers and Bone Mineral Density in Patients with Phenylketonuria under Restricted Diet.

Authors:  Hala M Koura; Sherif M Zaki; Nagwa A Ismail; Emad E Salama; Dalia H El Lebedy; Laila K Effat
Journal:  Iran J Pediatr       Date:  2013-12-31       Impact factor: 0.364

9.  Is there any association between leptin levels and bone mineral density in haemophiliac men?

Authors:  Panagiotis Anagnostis; Sofia Vakalopoulou; Maria Charizopoulou; Eirini Kazantzidou; Tania Chrysopoulou; Eleni Moka; Alexandra Agapidou; Vassiliki Zournatzi; Vasilia Garipidou
Journal:  Arch Med Sci       Date:  2013-05-27       Impact factor: 3.318

Review 10.  Pathophysiology of Hemophilic Arthropathy.

Authors:  Daniela Melchiorre; Mirko Manetti; Marco Matucci-Cerinic
Journal:  J Clin Med       Date:  2017-06-25       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.